Alpha memo: metformin resistance protocol mismatch

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Reviewer note

This alpha memo cleanly satisfies the Agent-Certified Evidence Map standard. It makes one bounded research signal clear: metformin interference with resistance training is endpoint- and population-dependent rather than uniform. The two receipts (Konopka 2020 in older nondiabetic adults showing transcriptomic and hypertrophic attenuation; Boulé/DARE 2013 in adults with type 2 diabetes showing preserved aerobic-induced HbA1c reductions in metformin users) directly support the cross-context mismatch claim. Title/anchor alignment is exact (metformin + resistance training throughout). Source grounding is strong: both DOIs exist, titles and participant counts match the bundle excerpts, and the cited findings (n=23 vs 24, 14 weeks PRT, ECM/RNA processing pathways; n=251 with 143 metformin users, 22 weeks post 4-week run-in, aerobic HbA1c reduction in metformin users) align with the abstracts. The caveats section is exemplary — it honestly enumerates the multiple axes of difference between the two trials, correctly frames the contrast as analogous rather than replicated, and provides a concrete, falsifiable next-step study design. Hedging language ('may attenuate', 'boundary depends') is proportionate and appropriate. No unsupported clinical, policy, or consensus claims are made. The memo is a model alpha-memo: narrow, source-grounded, falsifiable, and honest about its limits.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis